Summary
1.19 -0.06(-4.65%)07/08/2024
Zhongchao Inc (ZCMD)
Zhongchao Inc (ZCMD)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -4.65 | -6.82 | -5.38 | -44.09 | 251.03 | 3.37 | 0.00 | -69.25 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 1.19 | |
| Open | 1.19 | |
| High | 1.19 | |
| Low | 1.19 | |
| Volume | 629 | |
| Change | -0.06 | |
| Change % | -4.65 | |
| Avg Volume (20 Days) | 12,527 | |
| Volume/Avg Volume (20 Days) Ratio | 0.05 | |
| 52 Week Range | 0.29 - 3.62 | |
| Price vs 52 Week High | -67.13% | |
| Price vs 52 Week Low | 310.34% | |
| Range | -1.60 | |
| Gap Up/Down | -0.09 | |
Fundamentals | ||
| Market Capitalization (Mln) | 9 | |
| EBIDTA | 3,708,130 | |
| PE Ratio | 11.1875 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 0.00 | |
| Book Value | 1.3280 | |
| Earnings Per Share | 0.1600 | |
| EPS Estimate Current Quarter | 0.0000 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 0.0000 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | 0.1600 | |
| Revenues | ||
| Profit Marging | 0.2206 | |
| Operating Marging (TTM) | 0.1912 | |
| Return on asset (TTM) | 0.0646 | |
| Return on equity (TTM) | 0.1331 | |
| Revenue TTM | 18,143,110 | |
| Revenue per share TTM | 0.7280 | |
| Quarterly Revenue Growth (YOY) | 0.0180 | |
| Quarterly Earnings Growth (YOY) | -0.3410 | |
| Gross Profit (TTM) | 11,872,148 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 11.1875 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.2746 | |
| Revenue Enterprise Value | 1.4749 | |
| EBITDA Enterprise Value | 6.6842 | |
| Shares | ||
| Shares Outstanding | 18,085,400 | |
| Shares Float | 12,187,069 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 37.30 | |
| Institutions (%) | 0.20 | |
04/19 08:27 EST - investorplace.com
Why Is Zhongchao (ZCMD) Stock Up 103% Today?
Zhongchao (NASDAQ: ZCMD ) stock is rocketing higher on Friday alongside heavy trading of the Chinese healthcare information and training company's shares. That has more than 11.9 million shares of ZCMD stock changing hands as of this writing.
Why Is Zhongchao (ZCMD) Stock Up 103% Today?
Zhongchao (NASDAQ: ZCMD ) stock is rocketing higher on Friday alongside heavy trading of the Chinese healthcare information and training company's shares. That has more than 11.9 million shares of ZCMD stock changing hands as of this writing.
04/04 08:12 EST - investorplace.com
Why Is Zhongchao (ZCMD) Stock Up 40% Today?
Zhongchao (NASDAQ: ZCMD ) stock is soaring higher on Thursday alongside heavy pre-market trading of the Chinese healthcare information, education and training services company's shares. This has more than 5.3 million shares of ZCMD stock changing hands as of this writing.
Why Is Zhongchao (ZCMD) Stock Up 40% Today?
Zhongchao (NASDAQ: ZCMD ) stock is soaring higher on Thursday alongside heavy pre-market trading of the Chinese healthcare information, education and training services company's shares. This has more than 5.3 million shares of ZCMD stock changing hands as of this writing.
03/12 08:30 EST - prnewswire.com
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
SHANGHAI , March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment.
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
SHANGHAI , March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment.
03/05 07:54 EST - investorplace.com
Why Is Zhongchao (ZCMD) Stock Up 15% Today?
Zhongchao (NASDAQ: ZCMD ) stock is rising higher on Tuesday alongside heavy pre-market trading of the Chinese healthcare information, education, and training services company's shares this morning. This has more than 3.2 million shares of ZCMD stock changing hands during pre-market hours.
Why Is Zhongchao (ZCMD) Stock Up 15% Today?
Zhongchao (NASDAQ: ZCMD ) stock is rising higher on Tuesday alongside heavy pre-market trading of the Chinese healthcare information, education, and training services company's shares this morning. This has more than 3.2 million shares of ZCMD stock changing hands during pre-market hours.
02/27 08:00 EST - prnewswire.com
Zhongchao Inc. Announces 1-for-10 Share Consolidation
SHANGHAI , Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held on Tuesday, February 20, 2024, approved the proposed 1-for-10 share consolidation of the Company's ordinary shares of US$0.0001 par value each (the "Share Consolidation"). Beginning with the opening of trading on February 29, 2024, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP number of G9897X115.
Zhongchao Inc. Announces 1-for-10 Share Consolidation
SHANGHAI , Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held on Tuesday, February 20, 2024, approved the proposed 1-for-10 share consolidation of the Company's ordinary shares of US$0.0001 par value each (the "Share Consolidation"). Beginning with the opening of trading on February 29, 2024, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP number of G9897X115.
12/11 08:00 EST - prnewswire.com
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
SHANGHAI , Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization dedicated to enhancing Chinese citizens' health through public welfare initiatives and aid programs.
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
SHANGHAI , Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization dedicated to enhancing Chinese citizens' health through public welfare initiatives and aid programs.
10/23 08:00 EST - prnewswire.com
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
SHANGHAI , Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that its Zhongxin platform launched a WeChat mini program of Breast Cancer Follow-up Visit and Health Management Patient Guide (the "Guide") on Breast Cancer Awareness Day. The Guide aims to provide comprehensive reference for breast cancer patients and support their health management and disease recovery through every stage of their medical journey.
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
SHANGHAI , Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that its Zhongxin platform launched a WeChat mini program of Breast Cancer Follow-up Visit and Health Management Patient Guide (the "Guide") on Breast Cancer Awareness Day. The Guide aims to provide comprehensive reference for breast cancer patients and support their health management and disease recovery through every stage of their medical journey.
09/25 08:00 EST - prnewswire.com
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
SHANGHAI , Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the introduction of its Patient-Reported Outcome (PRO) -based symptom management model.
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
SHANGHAI , Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the introduction of its Patient-Reported Outcome (PRO) -based symptom management model.
08/24 08:00 EST - prnewswire.com
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
SHANGHAI , Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced it has achieved a milestone of serving over 10,000 breast cancer patients in China with comprehensive disease management services since 2021. By offering disease management services, Zhongchao aims to ensure effective medical treatments while reducing financial hardships and enhance the overall quality of life for these patients.
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
SHANGHAI , Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced it has achieved a milestone of serving over 10,000 breast cancer patients in China with comprehensive disease management services since 2021. By offering disease management services, Zhongchao aims to ensure effective medical treatments while reducing financial hardships and enhance the overall quality of life for these patients.
07/11 08:00 EST - prnewswire.com
Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education
SHANGHAI , July 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that it cooperates with Shanghai Ximalaya Technology Co., Ltd. ("Ximalaya"), a widely popular Chinese online audio sharing platform in China, to launch the first series of audio courses dedicated to cancer education.
Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education
SHANGHAI , July 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that it cooperates with Shanghai Ximalaya Technology Co., Ltd. ("Ximalaya"), a widely popular Chinese online audio sharing platform in China, to launch the first series of audio courses dedicated to cancer education.
02/08 09:38 EST - pennystocks.com
Penny Stocks To Buy Now? 5 To Watch After News This Week
Stock Market News Has These Penny Stocks On Traders' Watch Lists This Week. The post Penny Stocks To Buy Now?
Penny Stocks To Buy Now? 5 To Watch After News This Week
Stock Market News Has These Penny Stocks On Traders' Watch Lists This Week. The post Penny Stocks To Buy Now?
09/17 06:30 EST - prnewswire.com
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment
SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform").
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment
SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform").
09/10 06:30 EST - prnewswire.com
Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market
SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd.
Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market
SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd.
08/25 08:30 EST - prnewswire.com
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market
SHANGHAI, Aug. 25, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") provides patient follow-up management services for ovarian cancer patients from Zeyoulexiang Patient Assistance Project (the "Project"), helping ovarian cancer patients improve treatment outcomes and eventually increase survival rate.
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market
SHANGHAI, Aug. 25, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") provides patient follow-up management services for ovarian cancer patients from Zeyoulexiang Patient Assistance Project (the "Project"), helping ovarian cancer patients improve treatment outcomes and eventually increase survival rate.
08/12 08:30 EST - prnewswire.com
Zhongchao Inc. Builds A Patient DOT Management System
SHANGHAI, China, Aug. 12, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") launches Treatment Outcome Oriented DOT Management System ("DOT Management System") to accelerate the development of patient management business, meeting the increasing demand in tumor and rare disease patient management market.
Zhongchao Inc. Builds A Patient DOT Management System
SHANGHAI, China, Aug. 12, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") launches Treatment Outcome Oriented DOT Management System ("DOT Management System") to accelerate the development of patient management business, meeting the increasing demand in tumor and rare disease patient management market.
07/27 08:30 EST - prnewswire.com
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
SHANGHAI, July 27, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 100,000 users had completed the learnings through the Breast Cancer Tiered Diagnosis and Treatment Improvement Platform ("Platform") built and operated by the Company. There are approximately 2.5 million breast cancer patients in China, with more than 400,000 new cases each year.
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
SHANGHAI, July 27, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 100,000 users had completed the learnings through the Breast Cancer Tiered Diagnosis and Treatment Improvement Platform ("Platform") built and operated by the Company. There are approximately 2.5 million breast cancer patients in China, with more than 400,000 new cases each year.
07/01 08:30 EST - prnewswire.com
Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management
SHANGHAI, July 1, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, announced the establishment of a new subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. ("Zhongxin Ningxia") under Shanghai Zhongxin Medical Technology Co., Ltd.
Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management
SHANGHAI, July 1, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, announced the establishment of a new subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. ("Zhongxin Ningxia") under Shanghai Zhongxin Medical Technology Co., Ltd.
06/29 04:39 EST - seekingalpha.com
Zhongchao: Cheap Growth And Value Healthcare Education Stock
Zhongchao: Cheap Growth And Value Healthcare Education Stock
Zhongchao: Cheap Growth And Value Healthcare Education Stock
Zhongchao: Cheap Growth And Value Healthcare Education Stock
06/16 06:30 EST - prnewswire.com
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services
SHANGHAI, June 16, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. ("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE: ABBV) ("AbbVie").
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services
SHANGHAI, June 16, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today announced the cooperation in physician education with AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd. ("AbbVie Shanghai"), a subsidiary of AbbVie Inc (NYSE: ABBV) ("AbbVie").
06/03 06:30 EST - prnewswire.com
Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai
SHANGHAI, June 3, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the on-going one-year joint project of leukemia diagnosis and treatment courses (the "Project") that the Company has been hosting with Beijing Bethune Charitable Foundation ("Bethune Foundation") and BeiGene Pharmaceutical (Shanghai) Co., Ltd. ("BeiGene Shanghai"), a subsidiary of BeiGene, Ltd.
Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai
SHANGHAI, June 3, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the on-going one-year joint project of leukemia diagnosis and treatment courses (the "Project") that the Company has been hosting with Beijing Bethune Charitable Foundation ("Bethune Foundation") and BeiGene Pharmaceutical (Shanghai) Co., Ltd. ("BeiGene Shanghai"), a subsidiary of BeiGene, Ltd.